A patient came to the hospital with complaints of lethargy, increased sleep, and weight gain. Investigations revealed low plasma TSH concentration. However, on the administration of TRH, the TSH levels increased. Which of the conditions is likely in this patient?

Correct Answer: B. Hypothyroidism due to disease in the pituitary

The clinical presentation of lethargy, increased sleep, and weight gain indicates hypothyroidism. The key discriminator is the low baseline TSH that rises appropriately after TRH administration. This pattern is pathognomonic for secondary hypothyroidism due to pituitary disease.

In the hypothalamic-pituitary-thyroid (HPT) axis, TRH (thyrotropin-releasing hormone) from the hypothalamus stimulates the anterior pituitary to release TSH, which then stimulates thyroid hormone production. When pituitary disease damages thyrotroph cells, TSH production fails, leading to low T3/T4 and low baseline TSH. However, the pituitary retains some capacity to respond to exogenous TRH stimulation—hence TSH rises after TRH administration.

This distinguishes it from hypothalamic disease (tertiary hypothyroidism), where the pituitary itself is intact but receives no TRH signal, so it cannot respond to exogenous TRH. The clinical symptoms (myxedema-like features) combined with this specific TSH response pattern confirms secondary hypothyroidism from pituitary pathology—common causes in India include pituitary adenomas, post-surgical/radiation changes, or Sheehan's syndrome in postpartum women. The intact TRH-TSH response axis distal to the pituitary is the diagnostic hallmark.

Why the other options are wrong

A. Hyperthyroidism due to primary thyroid disease — This is wrong because the clinical presentation is clearly hypothyroid (lethargy, weight gain, increased sleep), not hyperthyroid. Primary hyperthyroidism would present with weight loss, anxiety, and tachycardia. Additionally, in primary hyperthyroidism, TSH is suppressed due to negative feedback from high T3/T4—it would not rise after TRH. The entire clinical picture contradicts this option. C. Hypothyroidism due to disease in the hypothalamus — This is wrong because hypothalamic disease (tertiary hypothyroidism) presents with low TSH but the pituitary cannot respond to exogenous TRH—TSH would remain low or show minimal rise. In this patient, TSH rises appropriately after TRH, proving the pituitary thyrotrophs are functional. This response indicates the defect is at the pituitary level, not the hypothalamus. NBE trap: students may confuse the location of the lesion. D. Hyperthyroidism due to disease in the pituitary — This is wrong because the clinical presentation is hypothyroid, not hyperthyroid. Pituitary disease causing hyperthyroidism is extremely rare and would require a TSH-secreting pituitary adenoma, which presents with elevated TSH and high T3/T4—opposite of this case. The low TSH and clinical hypothyroid symptoms rule out this option entirely.

High-Yield Facts

Mnemonics

TSH Response Pattern (2° vs 3° Hypothyroidism) 2° (Pituitary): TSH low → TRH given → TSH rises (pituitary intact, just starved of TRH). 3° (Hypothalamic): TSH low → TRH given → TSH stays low (pituitary damaged or unresponsive). Memory: Pituitary is like a sleeping worker—give it a signal (TRH) and it wakes up; hypothalamic lesion means the worker is broken. HPT Axis Lesion Localization Primary (thyroid): ↑TSH, ↓T4. Secondary (pituitary): ↓TSH, ↓T4, TRH-responsive. Tertiary (hypothalamus): ↓TSH, ↓T4, TRH-unresponsive. Use TRH stimulation to separate 2° from 3°.

NBE Trap

NBE pairs low TSH with hypothyroidism to trap students who reflexively think "low TSH = hyperthyroidism." The TRH response is the key discriminator that separates pituitary from hypothalamic disease—students who skip the TRH result will misread this as tertiary hypothyroidism.

Clinical Pearl

In Indian clinical practice, Sheehan's syndrome (postpartum pituitary necrosis) is a common cause of secondary hypothyroidism in women presenting with lethargy and weight gain months after delivery. The TRH stimulation test is the bedside gold standard to confirm pituitary reserve and differentiate it from hypothalamic disease before starting replacement therapy.

_Reference: Harrison Ch. 405 (Hypothyroidism); KD Tripathi Ch. 32 (Thyroid Hormones & Antithyroid Drugs)_